about
Correcting oral contraceptive pharmacokinetic alterations due to obesity: a randomized controlled trial.Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic-pituitary-ovarian activityProlonged monitoring of ethinyl estradiol and levonorgestrel levels confirms an altered pharmacokinetic profile in obese oral contraceptives users.Perspectives on variability in pharmacokinetics of an oral contraceptive product.Estimating systemic exposure to levonorgestrel from an oral contraceptive.Possible interaction between oxcarbazepine and an oral contraceptive.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 1990
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacokinetics of gestagens: some problems.
@en
Pharmacokinetics of gestagens: some problems.
@nl
type
label
Pharmacokinetics of gestagens: some problems.
@en
Pharmacokinetics of gestagens: some problems.
@nl
prefLabel
Pharmacokinetics of gestagens: some problems.
@en
Pharmacokinetics of gestagens: some problems.
@nl
P1476
Pharmacokinetics of gestagens: some problems.
@en
P2093
K Fotherby
P304
P356
10.1016/0002-9378(90)90576-S
P407
P433
P577
1990-07-01T00:00:00Z